GB1533954A - Pyridoxine derivatives - Google Patents

Pyridoxine derivatives

Info

Publication number
GB1533954A
GB1533954A GB6976/77A GB697677A GB1533954A GB 1533954 A GB1533954 A GB 1533954A GB 6976/77 A GB6976/77 A GB 6976/77A GB 697677 A GB697677 A GB 697677A GB 1533954 A GB1533954 A GB 1533954A
Authority
GB
United Kingdom
Prior art keywords
pyridoxine derivatives
pyridoxine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6976/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parcor SARL
Original Assignee
Parcor SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor SARL filed Critical Parcor SARL
Publication of GB1533954A publication Critical patent/GB1533954A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB6976/77A 1976-02-20 1977-02-18 Pyridoxine derivatives Expired GB1533954A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7604825A FR2341311A1 (fr) 1976-02-20 1976-02-20 Derives de la pyridoxine

Publications (1)

Publication Number Publication Date
GB1533954A true GB1533954A (en) 1978-11-29

Family

ID=9169423

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6976/77A Expired GB1533954A (en) 1976-02-20 1977-02-18 Pyridoxine derivatives

Country Status (10)

Country Link
JP (1) JPS6042792B2 (da)
BE (1) BE851461A (da)
DE (1) DE2707135A1 (da)
DK (1) DK146509C (da)
ES (1) ES456048A1 (da)
FR (1) FR2341311A1 (da)
GB (1) GB1533954A (da)
IE (1) IE44696B1 (da)
LU (1) LU76787A1 (da)
NL (1) NL7701666A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428640A1 (fr) * 1978-06-12 1980-01-11 Parcor Derives de pyridoxine, leur procede de preparation et leur application therapeutique
JPH0515517U (ja) * 1991-07-31 1993-02-26 日本電気株式会社 一次放射器取付け構造
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
WO2024084056A1 (en) * 2022-10-21 2024-04-25 Etherna Immunotherapies Nv Ionizable lipids

Also Published As

Publication number Publication date
JPS6042792B2 (ja) 1985-09-25
DE2707135A1 (de) 1977-08-25
DK146509C (da) 1984-04-02
ES456048A1 (es) 1978-02-16
IE44696B1 (en) 1982-02-24
BE851461A (fr) 1977-08-16
NL7701666A (nl) 1977-08-23
FR2341311B1 (da) 1979-10-05
FR2341311A1 (fr) 1977-09-16
IE44696L (en) 1977-08-20
LU76787A1 (da) 1977-07-06
DK69777A (da) 1977-08-21
DK146509B (da) 1983-10-24
JPS52122375A (en) 1977-10-14

Similar Documents

Publication Publication Date Title
PH14332A (en) 4-hydroxyphenylalkanolamine derivatives
GB1557637A (en) Pyridine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
HK9585A (en) Nogarol derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
PT66360A (en) Nicotinoylaminotriazine derivatives
GB1533954A (en) Pyridoxine derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
IL52270A0 (en) Hydrazinopyridazine derivatives
JPS5297975A (en) Pyridine derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
AU2892477A (en) Pyridine derivatives
JPS5283852A (en) Pyridine derivatives
AU2680877A (en) Arylaminopyrimidine derivatives
JPS5283495A (en) Thienothiazine derivatives
PH13411A (en) 8-adnantylaninometryl ergolene derivatives
GB1544289A (en) Thiazolinotriazine derivatives
GB1535080A (en) Naphthacenequinone derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee